115 related articles for article (PubMed ID: 15735298)
1. Cost effectiveness of a community based research project to help women quit smoking.
Secker-Walker RH; Holland RR; Lloyd CM; Pelkey D; Flynn BS
Tob Control; 2005 Feb; 14(1):37-42. PubMed ID: 15735298
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
Cornuz J; Gilbert A; Pinget C; McDonald P; Slama K; Salto E; Paccaud F
Tob Control; 2006 Jun; 15(3):152-9. PubMed ID: 16728744
[TBL] [Abstract][Full Text] [Related]
4. Community-based youth tobacco control interventions: cost effectiveness of the Full Court Press project.
Ross H; Powell LM; Bauer JE; Levy DT; Peck RM; Lee HR
Appl Health Econ Health Policy; 2006; 5(3):167-76. PubMed ID: 17132031
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.
Gilbert AR; Pinget C; Bovet P; Cornuz J; Shamlaye C; Paccaud F
Tob Control; 2004 Jun; 13(2):190-5. PubMed ID: 15175539
[TBL] [Abstract][Full Text] [Related]
6. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.
Javitz HS; Swan GE; Zbikowski SM; Curry SJ; McAfee TA; Decker DL; Patterson R; Jack LM
Am J Manag Care; 2004 Mar; 10(3):217-26. PubMed ID: 15032259
[TBL] [Abstract][Full Text] [Related]
8. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
Thavorn K; Chaiyakunapruk N
Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
[TBL] [Abstract][Full Text] [Related]
12. Cost and effectiveness of the nationwide government-supported Smoking Cessation Clinics in the Republic of Korea.
Oh JK; Lim MK; Yun EH; Shin SH; Park EY; Park EC
Tob Control; 2013 May; 22(e1):e73-7. PubMed ID: 22752272
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease: evaluative study carried out in Spain.
Plans-Rubió P
Pharmacoeconomics; 1998 May; 13(5 Pt 2):623-43. PubMed ID: 17165328
[TBL] [Abstract][Full Text] [Related]
14. The cost effectiveness of telephone counselling to aid smoking cessation in Denmark: a modelling study.
Rasmussen SR
Scand J Public Health; 2013 Feb; 41(1):4-10. PubMed ID: 23160318
[TBL] [Abstract][Full Text] [Related]
15. A mass media programme to prevent smoking among adolescents: costs and cost effectiveness.
Secker-Walker RH; Worden JK; Holland RR; Flynn BS; Detsky AS
Tob Control; 1997; 6(3):207-12. PubMed ID: 9396105
[TBL] [Abstract][Full Text] [Related]
16. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Bolin K; Lindgren B; Willers S
Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.
Fiscella K; Franks P
JAMA; 1996 Apr; 275(16):1247-51. PubMed ID: 8601956
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
20. How cost-effective is 'No Smoking Day'?
Kotz D; Stapleton JA; Owen L; West R
Tob Control; 2011 Jul; 20(4):302-4. PubMed ID: 20472574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
